and that's teradyne.ere. one, teradyne worked closely in the mobility, market think smartphones, think apple. well adventist, it's peer, has more visibility in the current and -- given their focus on the gpu test market. to think nvidia, amd. that's the narrative the market has been rewarding right now. and when you look at fundamentally under the hood of teradyne, you see the market was really hoping for some type of growth this year. their guidance ultimately push that off to the second half of this year, because they see some weak this on the automotive side of their business. all in all, it's great at winning designs, they just need these designs to convert into volume. and that's taken a little while, because an eighth quarter drawdown, slow down, in their end markets. i'm staying away right now, you can remain patient if you hold. >> let's move on to a broad ridge financial, last stop of about 37% in the past year of training, just below its 50 day moving average. your trade on broadridge, david? >>